Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.

OK... thats more like it 109 - 110 sell level...

morning all

Interesting post from Nick2412 at the other place

Nick2412 - 29 Oct'04 - 09:47 - 469 of 504

Well, a bit of news and I understand BPRG are to 'launch' on Nasdaq today. No, I haven't been stuck in a time warp. It appears the Nasdaq people were disappointed in the anti-climax and lack of glitz on BPRG's listing day. I suppose they might be feeling a bit guilty as I think it was internal Nasdaq 'bureacracy' that moved the original listing day and impacted on all the high profile publicity schedules such as CNBC interviews.

Well, the good news is that they are having a 'launch' today. GH will be in New York and, yes, BPRG's name will be in lights in Time Square. Don't know if any media coverage has been arranged. Hope so. Anyway, this shouldn't be seen as the day when BPRG takes off in the U.S. It is just an initial start to a continuing process of raising BPRG's profile in the States.

It will be interesting to see if volumes are higher on Nasdaq. Personally I will be more than happy just to see a gradual climb in volumes on the U.S. Many, myself included, had unrealistic expectations of the immediate impact Nasdaq would bring.

There were several good posts prior to listing by U.S. investors that warned against expecting immediate fireworks. They emphasised that U.S. institutions would take several weeks doing due diligence and volume levels would take a while to build up.

Good info Janus.. and Nick2412.. thanks.. lets see.. could be
the news to tip 110..

Thanks for post, steady climb would be good rather than the huge rises and falls over the last year...

Big Al and Dil. You two are like a couple of Monty Python women clucking over the disgusting behaviour of the yobs outside. LOL. Keep up the entertainment :)

Dil: Been shopping?
Big Al: Nah. Been shopping!
Dil: What did you buy?
Big Al: A piston engine!
Dil: A piston engine? How do you cook it?
Big Al: You don't cook it!
Dil: You can't eat it raw!
Big Al: Well, no. Bought some BPRG as well!
Dil: Can't make money with that..............

........tbc

Going well today all,can`t see a quid appearing at the mo!!dam. Best of luck

Bones :-)

it appeared and you bottled it Dave

Dil,still waiting & waiting for a collapse on the dow,,there`s more air in this ftse,than there is in my/arh get out.

surely a collapse there would mean one here to since we always follow them like silly little puppydogs.

Bang on,,dil rushy 25/1 looking good now.

I aint in

dil,football 2004/2005,traders,have a look.

Finally holding at 108.....phew...

bradley007-Where to from here? possible news Tues!

Am I correct in thinking that we can expect announcement in regards recent court case, 02 Nov?

Dstorey

The next stage is indeed 2.11.04 - may not be finalised on the day though .

Ramrod, cheers...D

Nasdaq listings in America are not all they are promised to be, at least in the short term.

I learned this nearly a decade ago following Mid-States, a shell company re-named after a reverse takeover by a US car parts business. Its shares soared from penny status to 125p on excitement about its aim to list jointly on Nasdaq. The business was reporting sound profits and looked materially undervalued relative to US quoted rivals. But as soon as the listing became effective Mid-States shares dived. Having sold the car parts business, it is once again a shell.

As hopes gathered over a Nasdaq listing for BioProgress (the Aim-quoted developer of non-gelatin pills and other products) I wondered if there might be a similar effect. Certainly, this was a factor cautioning me against switching into BioProgress as its shares rose from about 100p to 130p.

After the Nasdaq listing became effective the shares promptly shed these gains. It looks like a trading rule of thumb to buy shares on the expectation of a Nasdaq listing and sell on the event - or even go short or establish a spread bet down.

A key hope with US listings is that they will attract a new range of shareholders. With a company such as BioProgress, there are sound long-term reasons for developing its profile in the US. Plenty of people here were buying its shares recently on the basis of its overall potential, not just the Nasdaq listing. But all the same, it does not necessarily follow that such a listing would bring in new buyers.

Traders should note the classic rise and fall, which has good odds of repeating itself in other shares. Long-term investors can certainly ignore all this "noise trading".

http://tinyurl.com/5r66u